Sharon Lim

Permira is acquiring Arysta LifeScience from rival Olympus Capital in a secondary deal, valuing the agrochemical business at $2.2 billion in Japan's largest buyout this year and Permira’s first in the country.

Permira is acquiring Arysta LifeScience from rival Olympus Capital in a secondary deal, valuing the agrochemical business at $2.2 billion in Japan's largest buyout this year and Permira’s first in the country.

Permira is acquiring Arysta LifeScience from rival Olympus Capital in a secondary deal, valuing the agrochemical business at $2.2 billion in Japan's largest buyout this year and Permira’s first in the country.

Baring Private Equity Asia has sold its remaining 11 percent holding in Hidili Industry Development in a block sale less than one month after the Chinese coking coal producer went public.

Baring Private Equity Asia has sold its remaining 11 percent holding in Hidili Industry Development in a block sale less than one month after the Chinese coking coal producer went public.

Baring Private Equity Asia has sold its remaining 11 percent holding in Hidili Industry Development in a block sale less than one month after the Chinese coking coal producer went public.

Baring Private Equity Asia has sold its remaining 11 percent holding in Hidili Industry Development in a block sale less than one month after the Chinese coking coal producer went public.

Tano Capital, a US private equity firm which focuses on China and India, is forming a joint venture with Darby Overseas Investments and Tianjin Port Tariff-Free Zone Investments, a local government-linked.

Tano Capital, a US private equity firm which focuses on China and India, is forming a joint venture with Darby Overseas Investments and Tianjin Port Tariff-Free Zone Investments, a local government-linked.

Tano Capital, a US private equity firm which focuses on China and India, is forming a joint venture with Darby Overseas Investments and Tianjin Port Tariff-Free Zone Investments, a local government-linked.